Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial.
about
Placebos without deception: a randomized controlled trial in irritable bowel syndromeReporting bias in medical research - a narrative reviewAlosetron for irritable bowel syndromeAlosetron: a case study in regulatory capture, or a victory for patients' rights?Components of placebo effect: randomised controlled trial in patients with irritable bowel syndromeA controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndromeEfficacy of on-demand asimadoline, a peripheral kappa-opioid agonist, in females with irritable bowel syndromeDiagnosis and treatment of diarrhea-predominant irritable bowel syndromeIrritable bowel syndrome: Is it "irritable brain" or "irritable bowel"?Acupuncture and regulation of gastrointestinal functionSome of the challenges in drug development for irritable bowel syndromeEffect of alosetron on theophylline pharmacokineticsDifferences in efficacy and safety of pharmaceutical treatments between men and women: an umbrella reviewIncidence of ischemic colitis and serious complications of constipation among patients using alosetron: systematic review of clinical trials and post-marketing surveillance data.Review article: tegaserod.Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome.Alosetron improves quality of life in women with diarrhea-predominant irritable bowel syndrome.CD4+ T cell-mediated immunological control of enterochromaffin cell hyperplasia and 5-hydroxytryptamine production in enteric infection.A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating.Irritable bowel syndrome: more than abdominal pain and bowel habit abnormalities.Pharmacologic and complementary and alternative medicine therapies for irritable bowel syndrome.Rifaximin and eluxadoline - newly approved treatments for diarrhea-predominant irritable bowel syndrome: what is their role in clinical practice alongside alosetron?Placebo effect in clinical trial design for irritable bowel syndromeComparison of long-term effects of cognitive-behavioral therapy versus mindfulness-based therapy on reduction of symptoms among patients suffering from irritable bowel syndromeWhich patients improve: characteristics increasing sensitivity to a supportive patient-practitioner relationship.Citalopram provides little or no benefit in nondepressed patients with irritable bowel syndrome.An Evidence-Based Look at Misconceptions in the Treatment of Patients with IBS-DBiological, clinical, and ethical advances of placebo effects.Recent developments in gastroenterology.Effects of bisacodyl on ascending colon emptying and overall colonic transit in healthy volunteers.'Gut health': a new objective in medicine?Cost-effectiveness of internet-based cognitive behavior therapy for irritable bowel syndrome: results from a randomized controlled trialRecent advances in pharmacological treatment of irritable bowel syndrome.Effect of electroacupuncture on visceral hyperalgesia, serotonin and fos expression in an animal model of irritable bowel syndrome.A randomised controlled trial on hypnotherapy for irritable bowel syndrome: design and methodological challenges (the IMAGINE study).Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.Effect of CCK-1 antagonist, dexloxiglumide, in female patients with irritable bowel syndrome: a pharmacodynamic and pharmacogenomic study.The challenge of developing new therapies for irritable bowel syndromeOptimizing outcomes with alosetron hydrochloride in severe diarrhea-predominant irritable bowel syndrome.The placebo effect in irritable bowel syndrome trials: a meta-analysis.
P2860
Q21091076-AD3371BA-9356-4965-8AAD-EB0026A5BA79Q21203744-B12781B2-DAED-447A-BA83-CCCF01D1A782Q24527219-058C74DC-4E85-4E5F-B3B9-8C03DB16E6B4Q24527220-D05759A2-78AD-44A8-B0C8-3A278AF8C5EAQ24647883-27C9F17F-03D3-456A-BA3E-111450CECDB2Q24680181-7F8C51AA-529E-4204-A0A1-A36FB257D975Q24684839-F3059867-6132-49BF-99CD-7E257D25E1BFQ26765272-80B79C57-77FC-4491-9EE3-AC2E88745F61Q26769908-AD611C50-4B0D-4891-9AA5-0DF837273905Q26799038-4828D96C-972F-4A27-B19C-06BE8AE456FEQ28362604-1C6B6528-66D4-4B1A-AAC3-8FCFAF2A8410Q28365915-8DBA0FF3-79A5-4E76-B928-BB91C0136685Q28474985-A784F42D-AB93-4375-94FE-709BD8C10E65Q31036400-E7D7EE13-56EF-4A79-88D1-A58AA03AA280Q32026539-57F47524-BF94-4D70-B576-FAA7F67D6A85Q32026613-5161081E-1749-4F7C-BDBB-A938932010BFQ32090597-B7A0E426-A5C3-4976-81C8-9DC0A70F8AD7Q33274027-346F139A-C950-453E-8884-A4716E1CBAB5Q33434046-CC536A04-C089-4864-85CF-817F70033F82Q33441714-D3734AC2-F7B2-467B-8017-A69C35D60DDBQ33451900-FC661CEC-E31C-49AC-9F92-AEE4CCC7EA11Q33466527-7C818449-1BC4-40A8-9DAB-8A6E0953C86DQ33586880-3B98520C-DDAC-4DFC-86E5-FEACB2903819Q33596819-0BE7F476-1857-452A-9F95-C87C846CEA1BQ33624179-3280651F-A4D7-49EC-82C3-A8D85D2C6A86Q33636450-A213FAE3-13A2-4CAF-B763-8980068E95BBQ33667183-8A4F4C25-EA1E-4811-9E9E-BC5EA160561DQ33703954-7A3F40A4-0666-4512-91C1-97949C95B1A1Q33813304-B0C43F0D-F19B-40DA-A90F-C02CAA00CC3BQ33823819-58FD8E4A-8AC5-4580-B2FE-4C6B0E9CC97EQ33845395-29A8E9D9-5FF4-426D-B55F-42A4F6026D8FQ33865172-5EF2E597-C97C-4C9A-890D-A5AEAA88FA3FQ33958853-C1640A98-7261-458F-A2C1-915D8E3A12BAQ34028451-FB97B6A1-7B26-4241-A42E-DA3704623452Q34106923-26CD5588-CF09-4B43-9B49-5F7A669A78D9Q34394157-83A6B4BD-5DE4-4222-B770-4AE36CE99448Q34399520-82139F0A-C1DC-4A0A-B58E-4AD7A8597CE3Q34408997-2A6A0D03-0C98-4526-A968-61F8C404277EQ34409173-29419180-057B-422F-A852-1A1CA7AE44D9Q34421382-D305A22E-083C-4305-99C5-6D8F12D8F2A5
P2860
Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Efficacy and safety of alosetr ...... sed, placebo-controlled trial.
@ast
Efficacy and safety of alosetr ...... sed, placebo-controlled trial.
@en
type
label
Efficacy and safety of alosetr ...... sed, placebo-controlled trial.
@ast
Efficacy and safety of alosetr ...... sed, placebo-controlled trial.
@en
prefLabel
Efficacy and safety of alosetr ...... sed, placebo-controlled trial.
@ast
Efficacy and safety of alosetr ...... sed, placebo-controlled trial.
@en
P2093
P1433
P1476
Efficacy and safety of alosetr ...... sed, placebo-controlled trial.
@en
P2093
A R Northcutt
A W Mangel
D McSorley
M Camilleri
P304
P356
10.1016/S0140-6736(00)02033-X
P407
P577
2000-03-01T00:00:00Z